An official website of the United States government.

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Safety Assessment RP1200 Disodium 5’-Guanylate

Objective

In accordance with Retained EU Regulation 1831/2003 on feed additives, the application RP 1200 for the use of disodium 5’-guanylate produced by fermentation with Corynebacterium stationis KCCM 10530 and Escherichia coli K-12 KFCC 11067 as a feed additive for all animal species from CJ Europe GmbH has been submitted for authorisation in each nation of Great Britain (GB). Whilst it was a Member State of the EU, the UK accepted the assessments of EFSA in respect of authorisations for regulated food and feed products. Since the end of the transition period, FSA/FSS has adopted equivalent technical guidance and quality assurance processes to be able to undertake GB risk assessments for regulated product applications. However, a number of applications have been received by GB where EFSA, prior to the end of the transition period, evaluated an application for the product for which an application is now made to GB. FSA/FSS has decided to make use of the EFSA risk assessment, where this is appropriate, in forming its opinion. Therefore, FSA/FSS risk assessors have reviewed the EFSA opinion2 for the application below in the context of intended GB use and have concluded that the intended uses are safe. In reviewing the EFSA risk assessment opinion the reviewers have verified that the standard approach as outlined in the relevant guidance3 has been followed and the arguments made are consistent with the data summarised in the opinion. Consideration has been given to the processes undertaken to ensure the opinions are robust and whether there are any aspects that would require further review such as specific issues for the countries of the GB. The result of the assessment is that the EFSA scientific opinions are adequate also for GB risk analysis. Therefore, a full risk assessment has not been performed by FSA/FSS.